Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFL8R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $108,632
Award facts
- Contract value 100% obligated
- $108,631.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $108,631.58 to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Dupixent 300 mg/2 ml pens with a completion date of February 2, 2026. This non-competitive delivery order utilizes firm fixed-price pricing and will be fulfilled from the awardee's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic immunosuppressant medication used to treat conditions including moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis, and is typically supplied to support military healthcare systems and the Defense Health Agency.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award vehicle valued at up to $999,999,999.00 through December 31, 2031, which authorizes the supply of a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities and federal healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated significant capacity to fulfill federal medical procurement requirements on a fully competitive basis across multiple therapeutic domains, including specialty medications, vaccines, and critical care materials.
Quick answers
Who was awarded contract SPE2DR26FFL8R?
SPE2DR26FFL8R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FFL8R worth?
The government has obligated $108,632 on SPE2DR26FFL8R.
Is contract SPE2DR26FFL8R an order under another contract?
Yes. SPE2DR26FFL8R is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL8R competed?
The extent of competition for SPE2DR26FFL8R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award